[EN] 1-(PYRIMIDIN-2-YL)-1H-INDAZOLES HAVING BUB1 KINASE INHIBITING ACTIVITY<br/>[FR] 1-(PYRIMIDIN-2-YL)-1H-INDAZOLES POSSÉDANT UNE ACTIVITÉ D'INHIBITION DE LA KINASE BUB1
申请人:BAYER PHARMA AG
公开号:WO2017148995A1
公开(公告)日:2017-09-08
The present invention relates to Bub1 kinase (= Budding uninhibited by benzimidazole kinase) inhibiting 1-(pyrimidin-2-yl)-1H-indazole compounds of formula (I), i.e. which therefore have potential to treat hyperprofilerative diseases such as cancer.